This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 2820 |
| CoV-2 | 1738 |
| COVID-19 | 1691 |
| M | 934 |
| PCR | 821 |
| China | 530 |
| RT | 451 |
| HIV | 450 |
| CoV | 413 |
| RSV | 355 |
| Health | 349 |
| Coronavirus | 345 |
| United | 338 |
| RNA | 330 |
| States | 330 |
| Wuhan | 327 |
| MERS | 313 |
| Disease | 297 |
| A | 264 |
| March | 246 |
| Clin | 240 |
| sha | 235 |
| S. | 212 |
| Table | 201 |
| CI | 199 |
| CT | 191 |
| Dis | 189 |
| ICU | 186 |
| M. | 173 |
| April | 169 |
| CAP | 168 |
| HCoV | 166 |
| NP | 165 |
| H1N1 | 163 |
| US | 162 |
| CDC | 162 |
| Hospital | 152 |
| Control | 149 |
| C | 145 |
| New | 142 |
| T | 134 |
| Prevention | 131 |
| Hong | 128 |
| TB | 127 |
| Kong | 126 |
| B | 126 |
| Diseases | 119 |
| January | 118 |
| East | 117 |
| Supplementary | 116 |
| Clinical | 116 |
| Infectious | 112 |
| IgG | 109 |
| Novel | 108 |
| World | 108 |
| IgM | 107 |
| University | 107 |
| National | 106 |
| Middle | 106 |
| BDV | 106 |
| NL63 | 105 |
| HBoV | 105 |
| ACE2 | 105 |
| South | 104 |
| Ebola | 103 |
| C. | 102 |
| May | 102 |
| Organization | 99 |
| ID | 97 |
| Influenza | 96 |
| CD4 | 96 |
| Africa | 96 |
| PLWH | 95 |
| II | 92 |
| York | 90 |
| ELISA | 90 |
| L | 89 |
| Korea | 87 |
| AYA | 87 |
| Centers | 87 |
| OC43 | 87 |
| mg | 87 |
| Study | 87 |
| PPE | 86 |
| Respiratory | 84 |
| Research | 82 |
| Pneumonia | 82 |
| Human | 82 |
| City | 82 |
| Society | 81 |
| PWH | 80 |
| Center | 80 |
| ARDS | 80 |
| HCQ | 77 |
| Group | 74 |
| Patients | 74 |
| Medical | 73 |
| Care | 73 |
| Transmission | 72 |
| IQR | 72 |
| FDA | 72 |
| H. | 71 |
| nan | 70 |
| HKU1 | 69 |
| COVID | 69 |
| America | 69 |
| RBV | 68 |
| HCWs | 68 |
| Syndrome | 67 |
| VE | 67 |
| HSCT | 66 |
| Ct | 66 |
| U.S. | 65 |
| Department | 65 |
| Institute | 64 |
| hydroxychloroquine | 63 |
| L. | 62 |
| Figure | 62 |
| February | 62 |
| December | 61 |
| meta | 60 |
| Inc. | 60 |
| Borna | 60 |
| Covid-19 | 59 |
| June | 59 |
| • | 58 |
| BCG | 57 |
| parainfluenza | 56 |
| S | 56 |
| Review | 56 |
| J | 55 |
| Infection | 55 |
| IL-6 | 55 |
| PS | 54 |
| COPD | 54 |
| IDSA | 53 |
| LRTI | 53 |
| Li | 53 |
| Wang | 53 |
| sera | 52 |
| Use | 52 |
| Gilead | 52 |
| CHIK | 52 |
| Staphylococcus | 51 |
| Sciences | 51 |
| Evaluation | 51 |
| BMI | 51 |
| Community | 50 |
| LUS | 50 |
| Legionella | 50 |
| Mycoplasma | 50 |
| Treatment | 50 |
| KSA | 49 |
| G | 49 |
| CNS | 49 |
| Roche | 48 |
| Committee | 48 |
| tocilizumab | 47 |
| J. | 47 |
| Detection | 47 |
| Association | 47 |
| Healthcare | 46 |
| < | 46 |
| N | 46 |
| lymphopenia | 45 |
| Viral | 45 |
| Impact | 45 |
| Public | 44 |
| P. | 44 |
| Mycobacterium | 44 |
| Laboratory | 44 |
| France | 44 |
| Characteristics | 44 |
| CFR | 43 |
| Hydroxychloroquine | 42 |
| Medicine | 42 |
| Risk | 42 |
| SAS | 42 |
| Singapore | 41 |
| Analysis | 41 |
| System | 40 |
| H5N1 | 40 |
| H3N2 | 40 |
| Gardens | 40 |
| F | 40 |
| Europe | 40 |
| Development | 40 |
| AOM | 39 |
| Antibody | 39 |
| Fisher | 39 |
| MRSA | 39 |
| Rapid | 39 |
| Province | 38 |
| NPS | 38 |
| Children | 38 |
| Canada | 38 |
| CRP | 38 |
| ED | 37 |
| CD8 | 37 |
| California | 37 |
| Asia | 37 |
| K. | 37 |
| azithromycin | 37 |
| metapneumovirus | 37 |
| RVI | 36 |
| PeV | 36 |
| Pandemic | 36 |
| NAI | 36 |
| July | 36 |
| Chinese | 36 |
| B. | 36 |
| ILI | 35 |
| American | 35 |
| Amoy | 35 |
| Drug | 35 |
| Emergency | 35 |
| Liu | 35 |
| International | 35 |
| R | 35 |
| Virus | 35 |
| Washington | 35 |
| doc_id | 35 |
| H7N9 | 34 |
| Ang | 34 |
| CSF | 34 |
| D. | 34 |
| EVD | 34 |
| Efficacy | 34 |
| FLNP | 34 |
| Form | 34 |
| Hubei | 34 |
| ICMJE | 34 |
| LRT | 34 |
| MT | 34 |
| R. | 34 |
| USA | 34 |
| WHO | 34 |
| catarrhalis | 34 |
| Kingdom | 33 |
| Board | 33 |
| Dr. | 33 |
| G. | 33 |
| Streptococcus | 33 |
| URTI | 33 |
| Report | 33 |
| A3 | 32 |
| West | 32 |
| Surveillance | 32 |
| MEE | 32 |
| Italy | 32 |
| CP | 32 |
| Administration | 32 |
| AIDS | 32 |
| A. | 32 |
| BPA | 31 |
| A(H1N1)pdm09 | 31 |
| ACABS | 31 |
| Pseudomonas | 31 |
| Disclosure | 31 |
| North | 31 |
| PSI | 31 |
| Guidelines | 30 |
| HCW | 30 |
| IFN | 30 |
| Germany | 30 |
| England | 30 |
| Hajj | 30 |
| Assessment | 30 |
| Infections | 30 |
| S1 | 30 |
| Testing | 30 |
| WBC | 30 |
| mAbs | 30 |
| Outcomes | 30 |
| Haemophilus | 29 |
| E | 29 |
| Effectiveness | 29 |
| Epidemiology | 29 |
| HIV-1 | 29 |
| Diagnosis | 29 |
| India | 29 |
| Merck | 29 |
| Mexico | 29 |
| st | 29 |
| LAMP | 29 |
| Foundation | 28 |
| Atlanta | 28 |
| COV-2 | 28 |
| Cox | 28 |
| Data | 28 |
| David | 28 |
| Kim | 28 |
| General | 28 |
| Meta | 28 |
| NAATs | 28 |
| Network | 28 |
| Saudi | 28 |
| Vietnam | 28 |
| Molecular | 27 |
| LAC | 27 |
| Workers | 27 |
| PCT | 27 |
| W. | 27 |
| HRV | 26 |
| A(H7N9 | 26 |
| Arabia | 26 |
| BAL | 26 |
| Chen | 26 |
| Chlamydia | 26 |
| Dr | 26 |
| HCV | 26 |
| Diagnostics | 26 |
| Japan | 26 |
| bronchoalveolar | 26 |
| Lancet | 26 |
| oseltamivir | 26 |
| mm | 26 |
| pleconaril | 26 |
| Pfizer | 26 |
| NAC | 26 |
| Management | 26 |
| HCP | 25 |
| Adults | 25 |
| Al | 25 |
| CA | 25 |
| CAFO | 25 |
| College | 25 |
| Day | 25 |
| E. | 25 |
| Vaccine | 25 |
| HR | 25 |
| NIRV | 25 |
| PSCC | 25 |
| Republic | 25 |
| U | 25 |
| remdesivir | 25 |
| kg | 25 |
| Mig | 25 |
| Institutional | 24 |
| Angiotensin | 24 |
| Cancer | 24 |
| CoV. | 24 |
| EBV | 24 |
| Food | 24 |
| Global | 24 |
| HCT | 24 |
| John | 24 |
| MDR | 24 |
| NAT | 24 |
| PEH | 24 |
| Rec | 24 |
| UK | 24 |
| Zhang | 24 |
| amoxicillin | 24 |
| CoV-1 | 23 |
| HBV | 23 |
| European | 23 |
| Diagnostic | 23 |
| ABO | 23 |
| Centre | 23 |
| Case | 23 |
| COVID19 | 23 |
| Lee | 23 |
| LFIA2 | 23 |
| Whitney | 23 |
| NPA | 23 |
| TCID | 23 |
| Taiwan | 23 |
| Team | 23 |
| Tuberculosis | 23 |
| Wenzhou | 23 |
| baricitinib | 23 |
| Spain | 23 |
| ע | 23 |
| H | 22 |
| Hospitalized | 22 |
| Hib | 22 |
| Acute | 22 |
| Factors | 22 |
| DNA | 22 |
| County | 22 |
| Lung | 22 |
| I | 22 |
| PK | 22 |
| Methods | 22 |
| SOT | 22 |
| Services | 22 |
| State | 22 |
| Vero | 22 |
| hepatitis | 22 |
| parechovirus | 22 |
| Outbreak | 22 |
| NAbs | 21 |
| Cape | 21 |
| HCoV-229E | 21 |
| Institutes | 21 |
| LRTD | 21 |
| MDA | 21 |
| Mann | 21 |
| A(H1N1 | 21 |
| NSAIDs | 21 |
| Probe | 21 |
| RAS | 21 |
| Toronto | 21 |
| Western | 21 |
| qRT | 21 |
| rIFN | 21 |
| People | 21 |
| LRTC | 20 |
| ATS | 20 |
| Abbott | 20 |
| Baricitinib | 20 |
| CFS | 20 |
| IgA | 20 |
| LDH | 20 |
| Luminex | 20 |
| Thailand | 20 |
| Therapy | 20 |
| Zhejiang | 20 |
| rRT | 20 |
| ritonavir | 20 |
| Ill | 19 |
| AP | 19 |
| ARI | 19 |
| BACKGROUND | 19 |
| BSL-3 | 19 |
| Beijing | 19 |
| Epidemic | 19 |
| Gambia | 19 |
| Gen | 19 |
| D | 19 |
| Investigation | 19 |
| Region | 19 |
| Yang | 19 |
| T. | 19 |
| Science | 19 |
| Ministry | 19 |
| Qiagen | 19 |
| hyperimmune | 19 |
| Panel | 19 |
| Neisseria | 19 |
| PE | 18 |
| Appendix | 18 |
| Australia | 18 |
| Chikungunya | 18 |
| CoV-2-specific | 18 |
| CoV2 | 18 |
| Comparison | 18 |
| Early | 18 |
| Editor | 18 |
| Netherlands | 18 |
| P | 18 |
| PIV-3 | 18 |
| presatovir | 18 |
| Pediatric | 18 |
| SPSS | 18 |
| Shire | 18 |
| Unit | 18 |
| VRS | 18 |
| Wisconsin | 18 |
| nd | 18 |
| Pacific | 18 |
| serologic | 18 |
| EUA | 17 |
| IFR | 17 |
| Georgia | 17 |
| F. | 17 |
| Lu | 17 |
| Dear | 17 |
| CMV | 17 |
| BRFSS | 17 |
| ITT | 17 |
| Commission | 17 |
| Maria | 17 |
| SNF | 17 |
| San | 17 |
| Trial | 17 |
| Utah | 17 |
| Working | 17 |
| bocavirus | 17 |
| Y. | 17 |
| Zimbabwe | 17 |
| Mary | 17 |
| Ethics | 16 |
| Mortality | 16 |
| Lopinavir | 16 |
| LFIA1 | 16 |
| GlaxoSmithKline | 16 |
| First | 16 |
| Associated | 16 |
| Effect | 16 |
| Cryptococcus | 16 |
| Cov-2 | 16 |
| Background | 16 |
| November | 16 |
| AngII | 16 |
| Abu | 16 |
| NAAT | 16 |
| Michael | 16 |
| October | 16 |
| Robert | 16 |
| PBPK | 16 |
| mL | 16 |
| hMPV | 16 |
| WU | 16 |
| School | 16 |
| Safety | 16 |
| Seattle | 16 |
| Response | 16 |
| Raymond | 16 |
| RVP | 16 |
| RCT | 16 |
| Program | 16 |
| PIV-1 | 16 |
| EC50 | 15 |
| NR | 15 |
| MIS | 15 |
| MHC | 15 |
| Interim | 15 |
| Epidemiological | 15 |
| Elizabeth | 15 |
| Patient | 15 |
| Chloroquine | 15 |
| Chan | 15 |
| COVID-2019 | 15 |
| BD | 15 |
| Anti | 15 |
| Americans | 15 |
| AR | 15 |
| Oxford | 15 |
| Guangzhou | 15 |
| Peter | 15 |
| Thoracic | 15 |
| RNAemia | 15 |
| Zika | 15 |
| Zhao | 15 |
| Wei | 15 |
| W | 15 |
| Union | 15 |
| 15 | |
| hRSV | 15 |
| Sweden | 15 |
| pa | 15 |
| Sun | 15 |
| Studies | 15 |
| Service | 15 |
| S2 | 15 |
| Supplemental | 15 |
| Dhabi | 14 |
| NIH | 14 |
| Mecca | 14 |
| James | 14 |
| IP-10 | 14 |
| IFA | 14 |
| Government | 14 |
| Cary | 14 |
| De | 14 |
| Columbia | 14 |
| CARV | 14 |
| Ablynx | 14 |
| ACE | 14 |
| Protection | 14 |
| Princess | 14 |
| RAAS | 14 |
| cid | 14 |
| Wu | 14 |
| ROK | 14 |
| virus | 14 |
| qPCR | 14 |
| cyclophilin | 14 |
| ± | 14 |
| bay | 14 |
| Vincent | 14 |
| URT | 14 |
| Thomas | 14 |
| Survey | 14 |
| Shenzhen | 14 |
| Sera | 14 |
| SD | 14 |
| Ritonavir | 14 |
| Fig | 13 |
| EV71 | 13 |
| FOB | 13 |
| Hospitalization | 13 |
| Francisco | 13 |
| Guidance | 13 |
| HUH7 | 13 |
| Council | 13 |
| Dynamics | 13 |
| Advisory | 13 |
| Convalescent | 13 |
| Cohort | 13 |
| Chronic | 13 |
| Chimerix | 13 |
| CID | 13 |
| Ansun | 13 |
| AST | 13 |
| Hepatitis | 13 |
| Systematic | 13 |
| K | 13 |
| Student | 13 |
| Load | 13 |
| ≥65 | 13 |
| van | 13 |
| disease | 13 |
| Young | 13 |
| Xu | 13 |
| VHD | 13 |
| nucleocapsid | 13 |
| Severe | 13 |
| Remdesivir | 13 |
| NYULH | 13 |
| NC | 13 |
| Microbiology | 13 |
| Martin | 13 |
| Saharan | 13 |
| Mark | 13 |
| Guideline | 12 |
| Enterobacteriaceae | 12 |
| Epstein | 12 |
| Features | 12 |
| GMT | 12 |
| Hamilton | 12 |
| Janssen | 12 |
| HTLV-1 | 12 |
| Household | 12 |
| III | 12 |
| Diamond | 12 |
| ER | 12 |
| August | 12 |
| Consortium | 12 |
| Child | 12 |
| Chicago | 12 |
| Cheng | 12 |
| Cell | 12 |
| Brucella | 12 |
| Barr | 12 |
| Azithromycin | 12 |
| Asymptomatic | 12 |
| AVN | 12 |
| AUC | 12 |
| -80 | 12 |
| IRB | 12 |
| HEV | 12 |
| Kaplan | 12 |
| September | 12 |
| LN | 12 |
| meatus | 12 |
| der | 12 |
| cytomegalovirus | 12 |
| chloroquine | 12 |
| Y | 12 |
| Wyeth | 12 |
| Wong | 12 |
| Transplant | 12 |
| Summary | 12 |
| Stata | 12 |
| Smallpox | 12 |
| ageusia | 12 |
| RD | 12 |
| NT | 12 |
| Pulmonary | 12 |
| LOS | 12 |
| Lin | 12 |
| NET | 12 |
| Medicare | 12 |
| Non | 12 |
| Pearson | 12 |
| Plasma | 12 |
| Practice | 12 |
| Practices | 12 |
| Flu | 11 |
| Immunization | 11 |
| French | 11 |
| Gram | 11 |
| Guo | 11 |
| HC | 11 |
| I. | 11 |
| Immune | 11 |
| Lassa | 11 |
| Information | 11 |
| Island | 11 |
| Jean | 11 |
| Jersey | 11 |
| Joint | 11 |
| London | 11 |
| Etiology | 11 |
| Facility | 11 |
| Alaska | 11 |
| Escherichia | 11 |
| Blood | 11 |
| 8) | 11 |
| A+B | 11 |
| ARB | 11 |
| Milwaukee | 11 |
| Antiviral | 11 |
| Astellas | 11 |
| CWB | 11 |
| Emerging | 11 |
| Chi | 11 |
| DPH | 11 |
| Declaration | 11 |
| Dickinson | 11 |
| Directigen | 11 |
| Drs | 11 |
| Long | 11 |
| Intensive | 11 |
| N. | 11 |
| Shanghai | 11 |
| Test | 11 |
| Time | 11 |
| UW | 11 |
| Universal | 11 |
| Upper | 11 |
| V | 11 |
| Yi | 11 |
| alisporivir | 11 |
| enteroviruses | 11 |
| gonorrhoeae | 11 |
| group | 11 |
| rd | 11 |
| | | 11 |
| N1 | 11 |
| עSD | 11 |
| Susan | 11 |
| alfa | 11 |
| Serologic | 11 |
| N95 | 11 |
| NIV | 11 |
| Nursing | 11 |
| Observational | 11 |
| Oseltamivir | 11 |
| P<0.001 | 11 |
| PPV | 11 |
| Schinazi | 11 |
| Park | 11 |
| Population | 11 |
| Presatovir | 11 |
| Prodesse | 11 |
| RBD | 11 |
| Renin | 11 |
| Sanofi | 11 |
| Jiang | 10 |
| Immunotec | 10 |
| Jonathan | 10 |
| HEPA | 10 |
| Hu | 10 |
| Helsinki | 10 |
| Kinetics | 10 |
| Geneva | 10 |
| KPSC | 10 |
| Nasopharyngeal | 10 |
| MN | 10 |
| Material | 10 |
| Meier | 10 |
| Michigan | 10 |
| NK | 10 |
| NM | 10 |
| OR | 10 |
| ORF1ab | 10 |
| Office | 10 |
| Davies | 10 |
| Finland | 10 |
| Act | 10 |
| Daniel | 10 |
| Binax | 10 |
| Patrick | 10 |
| ALT | 10 |
| ARTI | 10 |
| ATL | 10 |
| Acquired | 10 |
| Antigen | 10 |
| Bangladesh | 10 |
| Becton | 10 |
| Biosystems | 10 |
| DRSP | 10 |
| Boston | 10 |
| CFD | 10 |
| COI | 10 |
| Canadian | 10 |
| Cepheid | 10 |
| Chang | 10 |
| Chlamydophila | 10 |
| Comparative | 10 |
| Panton | 10 |
| Wales | 10 |
| Paul | 10 |
| antibody | 10 |
| Tocilizumab | 10 |
| V. | 10 |
| Valentine | 10 |
| Women | 10 |
| XDR | 10 |
| Yan | 10 |
| Yin | 10 |
| Zhu | 10 |
| association | 10 |
| Tables | 10 |
| darunavir | 10 |
| herpes | 10 |
| influenza | 10 |
| lopinavir | 10 |
| mid | 10 |
| multicentre | 10 |
| rhinorrhea | 10 |
| Pediatrics | 10 |
| Technology | 10 |
| Zealand | 10 |
| TNF | 10 |
| Screening | 10 |
| TND | 10 |
| Pneumocystis | 10 |
| Post | 10 |
| Presymptomatic | 10 |
| QT | 10 |
| Quantitative | 10 |
| Rebecca | 10 |
| SARS- | 10 |
| Scientific | 10 |
| Pleconaril | 10 |
| Shigella | 10 |
| Streptococcal | 10 |
| Switzerland | 10 |
| Supplement | 10 |
| TM | 10 |
| Specimens | 10 |
| Social | 10 |
| Sierra | 10 |
| HCAP | 9 |
| Distress | 9 |
| Dong | 9 |
| EMR | 9 |
| Education | 9 |
| Epidemiologic | 9 |
| Gregory | 9 |
| Guinea | 9 |
| H3 | 9 |
| IL-4 | 9 |
| Healthy | 9 |
| Huang | 9 |
| ICUs | 9 |
| Cui | 9 |
| IPC | 9 |
| IV | 9 |
| IVD | 9 |
| Interventions | 9 |
| LCMV | 9 |
| Defense | 9 |
| LLC | 9 |
| Critical | 9 |
| Applied | 9 |
| 3D | 9 |
| A1 | 9 |
| ACIP | 9 |
| ADM | 9 |
| Aerosol | 9 |
| Alexander | 9 |
| Amplicor | 9 |
| Ann | 9 |
| B19 | 9 |
| Coronaviruses | 9 |
| BinaxNOW | 9 |
| British | 9 |
| Candida | 9 |
| Carlos | 9 |
| Census | 9 |
| Chest | 9 |
| Choi | 9 |
| Combination | 9 |
| LFIA | 9 |
| Age | 9 |
| Laboratories | 9 |
| Scott | 9 |
| Seroprevalence | 9 |
| Spearman | 9 |
| StataCorp | 9 |
| TMPRSS2 | 9 |
| Texas | 9 |
| Timothy | 9 |
| War | 9 |
| Ying | 9 |
| Yu | 9 |
| drotrecogin | 9 |
| health | 9 |
| key | 9 |
| ≥20 | 9 |
| nucleoprotein | 9 |
| series | 9 |
| simplex | 9 |
| zanamivir | 9 |
| у1 | 9 |
| Lewis | 9 |
| Sean | 9 |
| monocyte | 9 |
| SIR | 9 |
| Nile | 9 |
| Results | 9 |
| LightCycler | 9 |
| Lilly | 9 |
| Louis | 9 |
| Martinez | 9 |
| Modeling | 9 |
| nan | 9 |
| NHIS | 9 |
| Marrow | 9 |
| O | 9 |
| PERCH | 9 |
| Personnel | 9 |
| Quebec | 9 |
| REDCap | 9 |
| Randomized | 9 |
| Recommendations | 9 |
| Ontario | 9 |
| Regional | 9 |
| GVHD | 8 |
| GvHD | 8 |
| Guide | 8 |
| Guangdong | 8 |
| GenBank | 8 |
| GVU6109 | 8 |
| E6 | 8 |
| Florida | 8 |
| Emily | 8 |
| EDs | 8 |
| Division | 8 |
| HI | 8 |
| District | 8 |
| HE | 8 |
| Intravenous | 8 |
| Homeless | 8 |
| IL | 8 |
| ISI | 8 |
| Ian | 8 |
| IgG1 | 8 |
| Illness | 8 |
| Incidence | 8 |
| Indian | 8 |
| Inhibitors | 8 |
| Jennifer | 8 |
| Jiangsu | 8 |
| Jun | 8 |
| Critically | 8 |
| DFA | 8 |
| Academy | 8 |
| Core | 8 |
| Contact | 8 |
| .05 | 8 |
| 16S | 8 |
| A(H2N2 | 8 |
| A2 | 8 |
| ACAS | 8 |
| ADI | 8 |
| AEs | 8 |
| Kawasaki | 8 |
| Adult | 8 |
| Affairs | 8 |
| Agency | 8 |
| Alisporivir | 8 |
| Andrew | 8 |
| Anne | 8 |
| Antibodies | 8 |
| Antimicrobial | 8 |
| Authorization | 8 |
| Bio | 8 |
| Bordetella | 8 |
| CFU | 8 |
| CPE | 8 |
| Carrier | 8 |
| Central | 8 |
| Charlson | 8 |
| Chile | 8 |
| Christopher | 8 |
| Connecticut | 8 |
| KI | 8 |
| Hannah | 8 |
| Klebsiella | 8 |
| YKD | 8 |
| Southern | 8 |
| SpO2 | 8 |
| Spanish | 8 |
| Statistical | 8 |
| TaqMan | 8 |
| Tests | 8 |
| Trials | 8 |
| Tx | 8 |
| UTM | 8 |
| VEGF | 8 |
| Verigene | 8 |
| Veterans | 8 |
| Wolff | 8 |
| Zambia | 8 |
| Series | 8 |
| Zhou | 8 |
| aOR | 8 |
| administration | 8 |
| benzathine | 8 |
| bronchiolitis | 8 |
| mass | 8 |
| meningitidis | 8 |
| min | 8 |
| myalgias | 8 |
| sulfamethoxazole | 8 |
| swine | 8 |
| transthoracic | 8 |
| Krankheit | 8 |
| Severity | 8 |
| Yong | 8 |
| Saliva | 8 |
| Pasteur | 8 |
| Kwok | 8 |
| SLE | 8 |
| Legionnaires | 8 |
| MD | 8 |
| MS2 | 8 |
| Marc | 8 |
| Marseille | 8 |
| Missouri | 8 |
| NS | 8 |
| OP | 8 |
| Organ | 8 |
| PIV | 8 |
| PVL | 8 |
| Multicenter | 8 |
| Protocol | 8 |
| S3 | 8 |
| Pathogenesis | 8 |
| Peng | 8 |
| Pharmacokinetics | 8 |
| Phase | 8 |
| Placebo | 8 |
| SAE | 8 |
| Presumed | 8 |
| Prince | 8 |
| ROC | 8 |
| Registry | 8 |
| Rhinovirus | 8 |
| HIRA | 7 |
| HK1 | 7 |
| Enzyme | 7 |
| Han | 7 |
| Hung | 7 |
| Guérin | 7 |
| ICD-9-CM | 7 |
| HGF | 7 |
| Fan | 7 |
| Genomic | 7 |
| Gates | 7 |
| G1 | 7 |
| Fund | 7 |
| Estimation | 7 |
| FL | 7 |
| Identification | 7 |
| IPTW | 7 |
| Lisa | 7 |
| Imaging | 7 |
| Induced | 7 |
| Emirate | 7 |
| MCP-1 | 7 |
| Lyme | 7 |
| Los | 7 |
| Leone | 7 |
| Leflunomide | 7 |
| Lake | 7 |
| LTHD | 7 |
| LC | 7 |
| Koch | 7 |
| Kathleen | 7 |
| KPC | 7 |
| Jason | 7 |
| Initial | 7 |
| Infected | 7 |
| Emory | 7 |
| Activity | 7 |
| ERT | 7 |
| Bill | 7 |
| Assay | 7 |
| Antonio | 7 |
| Antiretroviral | 7 |
| Anthony | 7 |
| Anna | 7 |
| Angeles | 7 |
| Alicia | 7 |
| Alan | 7 |
| Ain | 7 |
| AMTD | 7 |
| AFB | 7 |
| AE | 7 |
| A(H5N1 | 7 |
| A(H3N2 | 7 |
| Mali | 7 |
| Authority | 7 |
| Biotech | 7 |
| Dosing | 7 |
| CIA | 7 |
| Director | 7 |
| Diego | 7 |
| Collaborative | 7 |
| Cobas | 7 |
| Co | 7 |
| Cluster | 7 |
| Christine | 7 |
| Christian | 7 |
| Chiu | 7 |
| Catherine | 7 |
| Cases | 7 |
| Carolina | 7 |
| Cao | 7 |
| CPT | 7 |
| CLIA | 7 |
| MND | 7 |
| TI-2 | 7 |
| Marconi | 7 |
| choriomeningitis | 7 |
| amantadine | 7 |
| Ye | 7 |
| William | 7 |
| WI | 7 |
| Viruses | 7 |
| Virginia | 7 |
| Vanessa | 7 |
| Vanderbilt | 7 |
| VTM | 7 |
| VACCINES | 7 |
| Tran | 7 |
| Times | 7 |
| Tennessee | 7 |
| Tan | 7 |
| TDF | 7 |
| cefuroxime | 7 |
| mmol | 7 |
| Standards | 7 |
| myelitis | 7 |
| ≥1 | 7 |
| Materials | 7 |
| р6 | 7 |
| ward | 7 |
| vivo | 7 |
| virologic | 7 |
| tularensis | 7 |
| trimethoprim | 7 |
| tenofovir | 7 |
| serogroup | 7 |
| review | 7 |
| protein | 7 |
| picornavirus | 7 |
| penicillin | 7 |
| nsp15 | 7 |
| Swine | 7 |
| lavage | 7 |
| St. | 7 |
| Pleural | 7 |
| Persons | 7 |
| PRIORITY | 7 |
| Olfactory | 7 |
| Ocean | 7 |
| ORF1a | 7 |
| Northeast | 7 |
| NSAID | 7 |
| N2 | 7 |
| Moraxella | 7 |
| Model | 7 |
| Michelle | 7 |
| Methisazone | 7 |
| Sputum | 7 |
| Melinda | 7 |
| Matthew | 7 |
| Pharmaceuticals | 7 |
| Northern | 7 |
| SARI | 7 |
| QuickVue | 7 |
| Poisson | 7 |
| Spread | 7 |
| Self | 7 |
| Sarah | 7 |
| Reverse | 7 |
| Reporting | 7 |
| RCTs | 7 |
| Q3 | 7 |
| Q1 | 7 |
| Provincial | 7 |
| Procalcitonin | 7 |
| ProFlu-1 | 7 |
| Prevalence | 7 |
| Specific | 7 |
| IAV | 6 |
| Immunoglobulin | 6 |
| IL-10 | 6 |
| IVIG | 6 |
| GeneXpert | 6 |
| Index | 6 |
| Insurance | 6 |
| Hg | 6 |
| Interferon | 6 |
| Hill | 6 |
| Gu | 6 |
| Hamelin | 6 |
| Gene | 6 |
| Hall | 6 |
| HY | 6 |
| H1 | 6 |
| Grant | 6 |
| Gerber | 6 |
| JHM | 6 |
| Israel | 6 |
| Loop | 6 |
| Jeddah | 6 |
| Jeremy | 6 |
| MRR | 6 |
| GISAID | 6 |
| MRC | 6 |
| MEM | 6 |
| Lymphopenia | 6 |
| Lombardy | 6 |
| La | 6 |
| Kidney | 6 |
| Kevin | 6 |
| Kai | 6 |
| Jung | 6 |
| Juan | 6 |
| Journal | 6 |
| Jose | 6 |
| Jordan | 6 |
| Jin | 6 |
| Jie | 6 |
| GRADE | 6 |
| Anderson | 6 |
| G2 | 6 |
| Caledonia | 6 |
| CD3 | 6 |
| CCI | 6 |
| Burden | 6 |
| Brisbane | 6 |
| Borrelia | 6 |
| Baseline | 6 |
| Barcelona | 6 |
| Assays | 6 |
| Area | 6 |
| Antibiotic | 6 |
| Angela | 6 |
| AiCuris | 6 |
| Ahmed | 6 |
| Adam | 6 |
| Acinetobacter | 6 |
| A&B | 6 |
| María | 6 |
| CDD | 6 |
| Calmette | 6 |
| Failure | 6 |
| Chemical | 6 |
| Factor | 6 |
| FNA | 6 |
| Emergence | 6 |
| ET | 6 |
| ESR | 6 |
| ENT | 6 |
| EMC | 6 |
| Donald | 6 |
| Ding | 6 |
| DiaSorin | 6 |
| Denmark | 6 |
| Democratic | 6 |
| DHODH | 6 |
| Cytomegalovirus | 6 |
| Congo | 6 |
| Cochrane | 6 |
| Chu | 6 |
| Madrid | 6 |
| Application | 6 |
| Mini | 6 |
| Wan | 6 |
| drug | 6 |
| cobas | 6 |
| bioMérieux | 6 |
| and/ | 6 |
| Xpert | 6 |
| Wing | 6 |
| Wilcoxon | 6 |
| Welfare | 6 |
| Virology | 6 |
| Type | 6 |
| Virological | 6 |
| Victoria | 6 |
| Van | 6 |
| Vaccines | 6 |
| VHF | 6 |
| Untersuchungen | 6 |
| Ultrasound | 6 |
| Uganda | 6 |
| du | 6 |
| interferon | 6 |
| lactam | 6 |
| loratadine | 6 |
| NPV | 6 |
| ≥40 | 6 |
| ≥2 | 6 |
| у3 | 6 |
| ΔN | 6 |
| west | 6 |
| voriconazole | 6 |
| type | 6 |
| polyradiculitis | 6 |
| pneumococcus | 6 |
| p=0.001 | 6 |
| p<0.0001 | 6 |
| obliterans | 6 |
| methylprednisolone | 6 |
| meningococcus | 6 |
| mL. | 6 |
| lymphocytopenia | 6 |
| URTD | 6 |
| pH | 6 |
| Transport | 6 |
| PB | 6 |
| QIAamp | 6 |
| Project | 6 |
| Potential | 6 |
| Positive | 6 |
| Polymerase | 6 |
| Pediatr | 6 |
| Pathogens | 6 |
| PBS | 6 |
| Occupational | 6 |
| RLTEC | 6 |
| OD | 6 |
| O. | 6 |
| Novartis | 6 |
| Nigeria | 6 |
| Neonates | 6 |
| NTD | 6 |
| NSW | 6 |
| Tak | 6 |
| RA | 6 |
| Nucleocapsid | 6 |
| RR | 6 |
| Santiago | 6 |
| TNSS | 6 |
| Real | 6 |
| TIV | 6 |
| Systems | 6 |
| Station | 6 |
| Southeast | 6 |
| Smith | 6 |
| Sex | 6 |
| Stephen | 6 |
| Salt | 6 |
| Royal | 6 |
| STATA | 6 |
| SPSN | 6 |
| SLGT2 | 6 |
| SE | 6 |
| Retrospective | 6 |
| Ryan | 6 |
| Imperial | 5 |
| Inc | 5 |
| Infant | 5 |
| Inhibitor | 5 |
| Injury | 5 |
| Investigations | 5 |
| JAK | 5 |
| Isolation | 5 |
| Kaiser | 5 |
| Jack | 5 |
| Jacqueline | 5 |
| Jan | 5 |
| Iceland | 5 |
| Ji | 5 |
| Immunogenicity | 5 |
| Hirsch | 5 |
| ISARIC | 5 |
| Hutchinson | 5 |
| Hui | 5 |
| Hsu | 5 |
| Hospitals | 5 |
| Hopkins | 5 |
| Homelessness | 5 |
| Herpes | 5 |
| Hematologic | 5 |
| H7 | 5 |
| Green | 5 |
| Governor | 5 |
| Khan | 5 |
| 5 | |
| Keywords | 5 |
| May. | 5 |
| King | 5 |
| Kou | 5 |
| George | 5 |
| Multicentre | 5 |
| Morris | 5 |
| Morita | 5 |
| Minnesota | 5 |
| Min | 5 |
| Midwest | 5 |
| Michel | 5 |
| Mice | 5 |
| Medicaid | 5 |
| Mechanism | 5 |
| Measles | 5 |
| Massachusetts | 5 |
| Maryland | 5 |
| Marshall | 5 |
| Marie | 5 |
| Marais | 5 |
| Mandell | 5 |
| Malaria | 5 |
| MVS | 5 |
| MSD | 5 |
| MRI | 5 |
| MNT | 5 |
| MK2 | 5 |
| MIC | 5 |
| Log | 5 |
| Linda | 5 |
| Lausanne | 5 |
| Lai | 5 |
| Germans | 5 |
| CO | 5 |
| Gao | 5 |
| Bacterial | 5 |
| Cheung | 5 |
| Characterization | 5 |
| Chain | 5 |
| Chagas | 5 |
| Cardiovascular | 5 |
| CVD | 5 |
| NAA | 5 |
| CIs | 5 |
| CD1-restricted | 5 |
| Bo | 5 |
| Black | 5 |
| BioFire | 5 |
| Based | 5 |
| Bartonella | 5 |
| BPM | 5 |
| GSK | 5 |
| Asian | 5 |
| Aron | 5 |
| Army | 5 |
| Apple | 5 |
| Allison | 5 |
| Alison | 5 |
| Aldosterone | 5 |
| Aetiology | 5 |
| APV | 5 |
| APACHE | 5 |
| ANOVA | 5 |
| ACE-2 | 5 |
| ACC | 5 |
| AB | 5 |
| Chongqing | 5 |
| Clara | 5 |
| Cochran | 5 |
| Cohen | 5 |
| GHC | 5 |
| GAPDH | 5 |
| Fulton | 5 |
| Freeman | 5 |
| François | 5 |
| Fort | 5 |
| Findings | 5 |
| FTD | 5 |
| Expression | 5 |
| Exposure | 5 |
| Expert | 5 |
| Eun | 5 |
| Estate | 5 |
| Eric | 5 |
| Eli | 5 |
| Electronic | 5 |
| EZ | 5 |
| EWPC | 5 |
| EQA | 5 |
| EMRA | 5 |
| ECMO | 5 |
| Design | 5 |
| Departments | 5 |
| Deborah | 5 |
| DOH | 5 |
| Crisis | 5 |
| Common | 5 |
| Cologne | 5 |
| Collection | 5 |
| Murine | 5 |
| Henan | 5 |
| NGS | 5 |
| Vaccination | 5 |
| amplificatio | 5 |
| aeruginosa | 5 |
| acyclovir | 5 |
| Zheng | 5 |
| Yung | 5 |
| Year | 5 |
| Xiang | 5 |
| Woo | 5 |
| White | 5 |
| Wai | 5 |
| Waghmare | 5 |
| WLA | 5 |
| WCPHDC | 5 |
| Version | 5 |
| VRNAT | 5 |
| Syncytial | 5 |
| VCA | 5 |
| Tze | 5 |
| Turku | 5 |
| Trias | 5 |
| Travel | 5 |
| Titanji | 5 |
| Therapeutic | 5 |
| Teng | 5 |
| Temporal | 5 |
| Tecumseh | 5 |
| Technical | 5 |
| Task | 5 |
| Tang | 5 |
| TNA | 5 |
| arthralgia | 5 |
| bei | 5 |
| board | 5 |
| bronchoscopic | 5 |
| NTHi | 5 |
| -2a | 5 |
| ≥7 | 5 |
| ≥50 | 5 |
| −80 | 5 |
| β1a | 5 |
| α | 5 |
| ® | 5 |
| tympanocentesis | 5 |
| tachypnea | 5 |
| rimantadine | 5 |
| ribosomal | 5 |
| prednisone | 5 |
| pneumovirus | 5 |
| pandemic | 5 |
| p=0.002 | 5 |
| log(10 | 5 |
| linezolid | 5 |
| independent | 5 |
| immunoassays | 5 |
| ie | 5 |
| highdose | 5 |
| hap_011 | 5 |
| doxycycline | 5 |
| covid-19 | 5 |
| cm | 5 |
| clinicaltrials.gov | 5 |
| clavulanate | 5 |
| cART | 5 |
| TMP | 5 |
| national | 5 |
| Sydney | 5 |
| R0 | 5 |
| Queen | 5 |
| Quality | 5 |
| Pujol | 5 |
| Prophylaxis | 5 |
| Profile | 5 |
| Preparedness | 5 |
| Plasmodium | 5 |
| Pierre | 5 |
| Philippines | 5 |
| Philippe | 5 |
| Persistence | 5 |
| Performance | 5 |
| Pathogen | 5 |
| Patel | 5 |
| PaO | 5 |
| PRISMA | 5 |
| POC | 5 |
| PIV-2 | 5 |
| PA | 5 |
| P=0.01 | 5 |
| Origin | 5 |
| ORCHID | 5 |
| NucliSENS | 5 |
| Nguyen | 5 |
| Neuraminidase | 5 |
| Nationwide | 5 |
| Natalie | 5 |
| Sung | 5 |
| NYC | 5 |
| Quellung | 5 |
| Otitis | 5 |
| RP | 5 |
| Sara | 5 |
| Statistics | 5 |
| Strategies | 5 |
| Rabbit | 5 |
| Statement | 5 |
| St | 5 |
| Spike | 5 |
| Sites | 5 |
| Simcyp | 5 |
| Short | 5 |
| Shi | 5 |
| Sheng | 5 |
| Shen | 5 |
| Seasonal | 5 |
| Scynexis | 5 |
| Smell | 5 |
| Santa | 5 |
| SAEs | 5 |
| Recovery | 5 |
| Rates | 5 |
| Responses | 5 |
| Rosenberg | 5 |
| Rural | 5 |
| Richard | 5 |
| SMR | 5 |
| SMX | 5 |
| SSTI | 5 |
| ST | 5 |
| Sandra | 5 |
| Resource | 5 |
| Henry | 4 |
| High | 4 |
| Hua | 4 |
| Histopathologic | 4 |
| Ho | 4 |
| Hodgkin | 4 |
| Hoffmann | 4 |
| Holmes | 4 |
| Host | 4 |
| House | 4 |
| IL-2 | 4 |
| Humoral | 4 |
| ICAM-1 | 4 |
| ICD-10 | 4 |
| IL-1 | 4 |
| Inpatients | 4 |
| IPD | 4 |
| IPW | 4 |
| Ig | 4 |
| Implications | 4 |
| HbA1c | 4 |
| Incubation | 4 |
| Hematopoietic | 4 |
| GS | 4 |
| Harrison | 4 |
| GIN | 4 |
| Fever | 4 |
| Internal | 4 |
| FluSurv | 4 |
| Fluent | 4 |
| Francisella | 4 |
| Francois | 4 |
| Fred | 4 |
| Froedtert | 4 |
| Fry | 4 |
| GGO | 4 |
| GS-5734 | 4 |
| Hao | 4 |
| Gary | 4 |
| Gender | 4 |
| Genomics | 4 |
| GraphPad | 4 |
| Gwaltney | 4 |
| HEp-2 | 4 |
| HID | 4 |
| HKU-1 | 4 |
| HMPV | 4 |
| Hans | 4 |
| Interleukin-6 | 4 |
| Lindsey | 4 |
| Intervention | 4 |
| MS | 4 |
| Level | 4 |
| Limei | 4 |
| Lindsay | 4 |
| Lionel | 4 |
| Luis | 4 |
| Luo | 4 |
| Lynch | 4 |
| López | 4 |
| MA | 4 |
| MMWR | 4 |
| Ma | 4 |
| Invitrogen | 4 |
| MacConkey | 4 |
| Malik | 4 |
| Man | 4 |
| Mantel | 4 |
| Marburg | 4 |
| Martínez | 4 |
| Maternal | 4 |
| Max | 4 |
| McMaster | 4 |
| Farley | 4 |
| Leo | 4 |
| Le | 4 |
| Lawrence | 4 |
| Laura | 4 |
| Jackson | 4 |
| Janus | 4 |
| Jessica | 4 |
| Jiangxia | 4 |
| Johnson | 4 |
| Jones | 4 |
| Jordi | 4 |
| Joseph | 4 |
| José | 4 |
| KKH | 4 |
| Kappa | 4 |
| Kazakhstan | 4 |
| Kenya | 4 |
| Key | 4 |
| Kimberly | 4 |
| Kirking | 4 |
| Kit | 4 |
| Korean | 4 |
| LAIV | 4 |
| LNTKE | 4 |
| Lau | 4 |
| Fauci | 4 |
| Biosciences | 4 |
| FLUC | 4 |
| Bonferroni | 4 |
| Bacteriology | 4 |
| Baidu | 4 |
| Barnaby | 4 |
| Bartlett | 4 |
| Basel | 4 |
| Bayer | 4 |
| Bellevue | 4 |
| Bhattacharyya | 4 |
| BioCryst | 4 |
| Biological | 4 |
| Bornaschen | 4 |
| FEV | 4 |
| Branche | 4 |
| Brazil | 4 |
| Brian | 4 |
| Britain | 4 |
| Broad | 4 |
| Buono | 4 |
| Bureau | 4 |
| CD40 | 4 |
| CH | 4 |
| CHT | 4 |
| Bacille | 4 |
| BTS | 4 |
| BK | 4 |
| B8 | 4 |
| Medium | 4 |
| -King | 4 |
| ABI | 4 |
| ACEI | 4 |
| ACEi | 4 |
| AGA | 4 |
| AQ | 4 |
| Access | 4 |
| Achilles | 4 |
| African | 4 |
| Ali | 4 |
| Allergy | 4 |
| Ambulatory | 4 |
| Amy | 4 |
| Ana | 4 |
| Analyses | 4 |
| Andrea | 4 |
| Armstrong | 4 |
| Art | 4 |
| Asthma | 4 |
| Avian | 4 |
| CMI | 4 |
| COVID- | 4 |
| CRIMS | 4 |
| Corticosteroids | 4 |
| DM | 4 |
| DOD | 4 |
| Daily | 4 |
| Dasu | 4 |
| Dawson | 4 |
| Delivery | 4 |
| Disparities | 4 |
| Ditan | 4 |
| Doxycycline | 4 |
| Dysfunction | 4 |
| Dysregulation | 4 |
| E5 | 4 |
| EIA | 4 |
| EIN | 4 |
| EMA | 4 |
| Eastern | 4 |
| Edward | 4 |
| Encephalitis | 4 |
| Enterprise | 4 |
| Euroimmun | 4 |
| Evidence | 4 |
| Coxiella | 4 |
| Correlation | 4 |
| CRU | 4 |
| Corona | 4 |
| CTG | 4 |
| CURB-65 | 4 |
| Cardiology | 4 |
| Caroline | 4 |
| Carolyn | 4 |
| Charles | 4 |
| Che | 4 |
| Chia | 4 |
| Childhood | 4 |
| Christina | 4 |
| Cidofovir | 4 |
| Claire | 4 |
| Classification | 4 |
| Clinic | 4 |
| ClinicalTrials.gov | 4 |
| Clinigen | 4 |
| Collaboration | 4 |
| Colorado | 4 |
| Communicable | 4 |
| Comorbidities | 4 |
| Conference | 4 |
| Measures | 4 |
| Sanjib | 4 |
| Meltzer | 4 |
| Wayne | 4 |
| Tukey | 4 |
| Tzu | 4 |
| UC | 4 |
| Ugandan | 4 |
| Update | 4 |
| ViiV | 4 |
| Vitro | 4 |
| WA | 4 |
| Wallis | 4 |
| Warren | 4 |
| Wellcome | 4 |
| Spring | 4 |
| Wilson | 4 |
| XX | 4 |
| Xenex | 4 |
| Xiao | 4 |
| Xin | 4 |
| Yuen | 4 |
| ZMapp | 4 |
| agar | 4 |
| anterior | 4 |
| antigen | 4 |
| Trust | 4 |
| Trivikram | 4 |
| Trends | 4 |
| Transplantation | 4 |
| Sulfanilamide | 4 |
| Swedish | 4 |
| TCB | 4 |
| TGA | 4 |
| TTA | 4 |
| TX | 4 |
| Tab | 4 |
| Tam | 4 |
| Taste | 4 |
| Tate | 4 |
| Tawaf | 4 |
| Telford | 4 |
| Term | 4 |
| Territorial | 4 |
| Tertiary | 4 |
| Thompson | 4 |
| Three | 4 |
| Toll | 4 |
| Torres | 4 |
| Toulouse | 4 |
| Town | 4 |
| b. | 4 |
| bacteriologic | 4 |
| cDNA | 4 |
| nLUS | 4 |
| neurotropic | 4 |
| odynophagia | 4 |
| organism(s | 4 |
| peptidase-4 | 4 |
| picornaviruses | 4 |
| pneumococcic | 4 |
| polyomavirus | 4 |
| psittacosis | 4 |
| q8h | 4 |
| rNP | 4 |
| range | 4 |
| rhesus | 4 |
| rt | 4 |
| sarilumab | 4 |
| therapy | 4 |
| upE | 4 |
| zoster | 4 |
| zur | 4 |
| β1b | 4 |
| ‡ | 4 |
| Meng | 4 |
| neoformans | 4 |
| n=17 | 4 |
| chemoattractant | 4 |
| methisazone | 4 |
| chemoprophylaxis | 4 |
| cidal | 4 |
| clarithromycin | 4 |
| del | 4 |
| disease-2019 | 4 |
| ebola | 4 |
| epi | 4 |
| fumarate | 4 |
| general | 4 |
| goat | 4 |
| hap_050 | 4 |
| immitis | 4 |
| immunoglobin | 4 |
| institutional | 4 |
| jejuni | 4 |
| leflunomide | 4 |
| mannan | 4 |
| medRxiv | 4 |
| meningitis | 4 |
| meningoencephalitis | 4 |
| meropenem | 4 |
| Stephanie | 4 |
| pneumococci | 4 |
| Spencer | 4 |
| PRIDE | 4 |
| Nobel | 4 |
| Normandy | 4 |
| Notes | 4 |
| Nucleic | 4 |
| Obesity | 4 |
| Ohio | 4 |
| Olivier | 4 |
| Optimized | 4 |
| Oral | 4 |
| PEP | 4 |
| PSO | 4 |
| Position | 4 |
| Pakistan | 4 |
| Palivizumab | 4 |
| Paris | 4 |
| Peiris | 4 |
| Penicillin | 4 |
| Pennsylvania | 4 |
| Pferde | 4 |
| Philip | 4 |
| Physicians | 4 |
| Po | 4 |
| Nina | 4 |
| Ng | 4 |
| Neonatal | 4 |
| Natural | 4 |
| Metapneumovirus | 4 |
| Spatial | 4 |
| MgCl | 4 |
| Microbiota | 4 |
| Miguel | 4 |
| Modelling | 4 |
| Monica | 4 |
| Monitoring | 4 |
| Morbidity | 4 |
| N-95 | 4 |
| N28D | 4 |
| NAATS | 4 |
| NCCLS | 4 |
| NHS | 4 |
| NICU | 4 |
| NSC | 4 |
| NY | 4 |
| NYU | 4 |
| Nanjing | 4 |
| Nanosphere | 4 |
| Native | 4 |
| Polymod | 4 |
| Mouse | 4 |
| President | 4 |
| Ruhe | 4 |
| SH | 4 |
| SIV | 4 |
| SOFA | 4 |
| SYBR | 4 |
| Salmonella | 4 |
| ≥10 | 4 |
| Schwartz | 4 |
| Se | 4 |
| Second | 4 |
| Seoul | 4 |
| Settings | 4 |
| Shandong | 4 |
| Shelter | 4 |
| Shin | 4 |
| Sigma | 4 |
| Silvia | 4 |
| Singh | 4 |
| Skilled | 4 |
| Press | 4 |
| Sp | 4 |
| Song | 4 |
| SAR | 4 |
| Silva | 4 |
| Rochester | 4 |
| RTD | 4 |
| Robin | 4 |
| Programs | 4 |
| Primary | 4 |
| Protein | 4 |
| Pulmotect | 4 |
| Qian | 4 |
| Qin | 4 |
| Quang | 4 |
| Quidel | 4 |
| RADT | 4 |
| Pérez | 4 |
| Rabold | 4 |
| Regulations | 4 |
| Ribavirin | 4 |
| Reyes | 4 |
| RdRp | 4 |
| Reviews | 4 |
| Reports | 4 |
| Projection | 4 |
| Reed | 4 |
| Receptor | 4 |
| HAM | 3 |
| Guillain | 3 |
| HA | 3 |
| H5 | 3 |
| H2N2 | 3 |
| H1N1pmd09 | 3 |
| H1N1-like | 3 |
| Guy | 3 |
| Gustatory | 3 |
| Gharpure | 3 |
| Giovanni | 3 |
| Greece | 3 |
| Great | 3 |
| Grady | 3 |
| Gordon | 3 |
| Gerard | 3 |
| Goods | 3 |
| Graham | 3 |
| Helicobacter | 3 |
| HCQ+AZ | 3 |
| Historical | 3 |
| IGRA | 3 |
| IDM | 3 |
| Gehirn | 3 |
| ID50 | 3 |
| Hyperimmune | 3 |
| Humans | 3 |
| Huanggang | 3 |
| Home | 3 |
| Histologic | 3 |
| HCUV | 3 |
| Herzog | 3 |
| Hee | 3 |
| HeLa | 3 |
| Hassan | 3 |
| Haenszel | 3 |
| HTLV | 3 |
| HSV | 3 |
| HLF | 3 |
| Genome | 3 |
| Fei | 3 |
| Gail | 3 |
| Eva | 3 |
| Fc | 3 |
| Family | 3 |
| FLUA | 3 |
| FC0010218 | 3 |
| FAM | 3 |
| Excellence | 3 |
| Examination | 3 |
| Evolution | 3 |
| EudraCT | 3 |
| Gageldonk | 3 |
| Ethical | 3 |
| Establishment | 3 |
| Erin | 3 |
| Erik | 3 |
| Epic | 3 |
| Environmental | 3 |
| IL-12 | 3 |
| English | 3 |
| Feb | 3 |
| Feng | 3 |
| Feria | 3 |
| FiO2 | 3 |
| GSH | 3 |
| GPS | 3 |
| GFR | 3 |
| Fung | 3 |
| Fu | 3 |
| Frequency | 3 |
| Free | 3 |
| Frederick | 3 |
| Foreign | 3 |
| Ford | 3 |
| Force | 3 |
| Fong | 3 |
| FluA+B | 3 |
| Fleming | 3 |
| FilmArray | 3 |
| File | 3 |
| Field | 3 |
| IHR | 3 |
| Kok | 3 |
| IL-18 | 3 |
| Lafeber | 3 |
| Loopamp | 3 |
| Longitudinal | 3 |
| Literature | 3 |
| Ling | 3 |
| Limitations | 3 |
| Leonardo | 3 |
| Laws | 3 |
| Lan | 3 |
| Lack | 3 |
| IL-8 | 3 |
| Laboratorios | 3 |
| LIJHS | 3 |
| LCM | 3 |
| Kruskal | 3 |
| Keri | 3 |
| Kennedy | 3 |
| Kendall | 3 |
| Keith | 3 |
| Lower | 3 |
| Ltd | 3 |
| Luc | 3 |
| Lucas | 3 |
| Elena | 3 |
| Manifestations | 3 |
| Male | 3 |
| Malaysia | 3 |
| Malak | 3 |
| Maine | 3 |
| MagnaPure | 3 |
| MagNA | 3 |
| Madin | 3 |
| MRC5 | 3 |
| MMR | 3 |
| MLST | 3 |
| MIRACLE | 3 |
| MHV | 3 |
| MAFFT | 3 |
| M2 | 3 |
| Luke | 3 |
| Kathryn | 3 |
| Kate | 3 |
| Karen | 3 |
| Interval | 3 |
| Inpatient | 3 |
| Initiative | 3 |
| Infective | 3 |
| Infanta | 3 |
| Individual | 3 |
| Indiana | 3 |
| Income | 3 |
| Improvement | 3 |
| Implementation | 3 |
| Immunodeficiency | 3 |
| Immunoassay | 3 |
| Immunity | 3 |
| Ignatius | 3 |
| IgM. | 3 |
| Icelandic | 3 |
| IVIg | 3 |
| INR | 3 |
| Interrupted | 3 |
| Inverness | 3 |
| Kansas | 3 |
| Investigators | 3 |
| KCDC | 3 |
| Jyh | 3 |
| Judith | 3 |
| Johns | 3 |
| Joel | 3 |
| Jingzhou | 3 |
| Jing | 3 |
| Jiao | 3 |
| Jeong | 3 |
| Jeni | 3 |
| Jeffrey | 3 |
| Jane | 3 |
| JBI | 3 |
| JAMA | 3 |
| JAK1/2 | 3 |
| Isothermal | 3 |
| Iran | 3 |
| Ellen | 3 |
| C28269 | 3 |
| El | 3 |
| Bias | 3 |
| Bornasche | 3 |
| Bonnie | 3 |
| Boma | 3 |
| Boghuma | 3 |
| Boca | 3 |
| Biosafety | 3 |
| Biologics | 3 |
| Bioline | 3 |
| BiPAP | 3 |
| Cambridge | 3 |
| Bernard | 3 |
| Berlin | 3 |
| Benjamin | 3 |
| Benefit | 3 |
| Belt | 3 |
| Belgium | 3 |
| Behavioral | 3 |
| Beckman | 3 |
| Botha | 3 |
| Bozzette | 3 |
| Bronchoalveolar | 3 |
| Brooks | 3 |
| CXR | 3 |
| CTC | 3 |
| CRS | 3 |
| COX-2 | 3 |
| COVID-19-like | 3 |
| COVID-19-Associated | 3 |
| CLSI | 3 |
| CLART | 3 |
| CKD | 3 |
| CF | 3 |
| CD27 | 3 |
| CD-1 | 3 |
| Map | 3 |
| C-8 | 3 |
| Bush | 3 |
| Bryson | 3 |
| Brussel | 3 |
| Barry | 3 |
| Barbara | 3 |
| Bacteroides | 3 |
| Affiliated | 3 |
| Activation | 3 |
| Action | 3 |
| Acquisition | 3 |
| Abdullah | 3 |
| AUROC | 3 |
| ATR | 3 |
| ATG | 3 |
| ATCC | 3 |
| AMPLICOR | 3 |
| AGE | 3 |
| AAG | 3 |
| A6 | 3 |
| A12 | 3 |
| 3DP | 3 |
| 2D | 3 |
| 2C | 3 |
| -HKU1 | 3 |
| AdvanDx | 3 |
| Agriculture | 3 |
| BB | 3 |
| Ai | 3 |
| Avidity | 3 |
| Austria | 3 |
| Argentina | 3 |
| Animal | 3 |
| Anh | 3 |
| Angiotensin(1 | 3 |
| Andhra | 3 |
| Amplification | 3 |
| AmpliTaq | 3 |
| Amphotericin | 3 |
| Americas | 3 |
| Amanda | 3 |
| Altman | 3 |
| Althoff | 3 |
| Allen | 3 |
| Alberta | 3 |
| Air | 3 |
| Cahn | 3 |
| Carbohydrate | 3 |
| Efforts | 3 |
| Darby | 3 |
| Dietrich | 3 |
| Dexamethasone | 3 |
| Devices | 3 |
| Description | 3 |
| Denis | 3 |
| Deng | 3 |
| Definitions | 3 |
| Debio | 3 |
| Danielle | 3 |
| Carlo | 3 |
| DPP-4 | 3 |
| DENV | 3 |
| Cytotoxic | 3 |
| Cytokine | 3 |
| Cyclophilins | 3 |
| Current | 3 |
| Cuomo | 3 |
| Cruise | 3 |
| Differences | 3 |
| Directors | 3 |
| Disease-19 | 3 |
| Distancing | 3 |
| Edwards | 3 |
| Edinburgh | 3 |
| Economic | 3 |
| EVD001 | 3 |
| EPICO | 3 |
| EEG | 3 |
| EDTA | 3 |
| ECS | 3 |
| EAC | 3 |
| E2 | 3 |
| Dynamic | 3 |
| Dunn | 3 |
| Dongni | 3 |
| Dominique | 3 |
| Dohme | 3 |
| Doctor | 3 |
| Dix | 3 |
| Cross | 3 |
| Criteria | 3 |
| Cristina | 3 |
| Cold | 3 |
| Coburn | 3 |
| CoVs | 3 |
| CoV-229E | 3 |
| Closures | 3 |
| Clearance | 3 |
| Clark | 3 |
| Chung | 3 |
| Chun | 3 |
| Christchurch | 3 |
| Chik | 3 |
| Chien | 3 |
| Chief | 3 |
| Chemoprophylaxis | 3 |
| Chemokine | 3 |
| Chemaly | 3 |
| Checklist | 3 |
| Chao | 3 |
| Coccidioides | 3 |
| Collateral | 3 |
| Cov2 | 3 |
| Computing | 3 |
| Coulter | 3 |
| Corticosteroid | 3 |
| Corporation | 3 |
| Coronavirus-2 | 3 |
| Coro | 3 |
| Cornell | 3 |
| Corman | 3 |
| Copan | 3 |
| Cooper | 3 |
| Controlled | 3 |
| Contribution | 3 |
| Continuing | 3 |
| Contacts | 3 |
| Consultation | 3 |
| Consensus | 3 |
| Conners | 3 |
| Congress | 3 |
| Manoj | 3 |
| Bing | 3 |
| Mar | 3 |
| Virologic | 3 |
| Wendy | 3 |
| Wen | 3 |
| Well | 3 |
| Wah | 3 |
| Wadhwa | 3 |
| WK | 3 |
| Vuong | 3 |
| Volunteers | 3 |
| Virkon | 3 |
| baumannii | 3 |
| Viljoen | 3 |
| Viiv | 3 |
| Vibrio | 3 |
| Veyer | 3 |
| Variation | 3 |
| Valley | 3 |
| Valencia | 3 |
| VZV | 3 |
| Werner | 3 |
| Westergaard | 3 |
| X | 3 |
| XL | 3 |
| arthralgias | 3 |
| apy | 3 |
| approved/ | 3 |
| anticapsular | 3 |
| anti | 3 |
| angiotensin | 3 |
| analysis | 3 |
| adjudication | 3 |
| Ziad | 3 |
| Zhonghua | 3 |
| Zaire | 3 |
| Yun | 3 |
| Yuan | 3 |
| Yip | 3 |
| Yao | 3 |
| Xie | 3 |
| Xiaogan | 3 |
| VL | 3 |
| Universidad | 3 |
| Units | 3 |
| TMR | 3 |
| TGEV | 3 |
| T.J. | 3 |
| T.A. | 3 |
| Synthetic | 3 |
| Swiss | 3 |
| Surgical | 3 |
| Suppl | 3 |
| Superspreading | 3 |
| Sultan | 3 |
| Sue | 3 |
| Subset | 3 |
| Su | 3 |
| Structure | 3 |
| Stockholm | 3 |
| Stewardship | 3 |
| Steven | 3 |
| Stefan | 3 |
| TGT | 3 |
| TN | 3 |
| Uber | 3 |
| TSPE | 3 |
| Tse | 3 |
| Tsang | 3 |
| Trump | 3 |
| Travelers | 3 |
| Transcriptase | 3 |
| Tracing | 3 |
| Total | 3 |
| Tool | 3 |
| Tongji | 3 |
| Tong | 3 |
| Tokyo | 3 |
| Tobias | 3 |
| Titers | 3 |
| Ting | 3 |
| Throat | 3 |
| Thornburg | 3 |
| Tai | 3 |
| axetil | 3 |
| bp | 3 |
| Standardization | 3 |
| peptidyl | 3 |
| risk.• | 3 |
| ribavirin | 3 |
| rhinovirus | 3 |
| rheumatoid | 3 |
| rRNA | 3 |
| q.d | 3 |
| presenceof | 3 |
| poxvirus | 3 |
| paranasal | 3 |
| bronchogram | 3 |
| parainfluenzaviruses | 3 |
| ostia | 3 |
| novo | 3 |
| nonbronchoscopic | 3 |
| nares | 3 |
| monitoring | 3 |
| microbiologic | 3 |
| metropolitan | 3 |
| scan | 3 |
| semilunaris | 3 |
| sinus | 3 |
| streptococcalpharyngitis | 3 |
| Mechanisms | 3 |
| | 3 |
| ≥5 | 3 |
| ≥25 | 3 |
| ≤ | 3 |
| −.02 | 3 |
| עSE | 3 |
| р2 | 3 |
| ϫ | 3 |
| μL | 3 |
| ° | 3 |
| tympanometry | 3 |
| turbidimeter | 3 |
| trans | 3 |
| tis | 3 |
| th | 3 |
| sulfapyridine | 3 |
| medical | 3 |
| med | 3 |
| measles | 3 |
| dueto | 3 |
| dipeptidyl | 3 |
| des | 3 |
| department | 3 |
| den | 3 |
| das | 3 |
| coxsackie | 3 |
| coronaviruses | 3 |
| committee | 3 |
| combination | 3 |
| clindamycin | 3 |
| cfu | 3 |
| census | 3 |
| cefpodoxime | 3 |
| cefaclor | 3 |